Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life study

• Pierre-Edouard Debureaux,
• Nathalie Forgeard,
• Dikelele Elessa,
• Stéphanie Harel,
• Laurent Frenzel,
• Bruno Royer,
• Alexis Talbot,
• Sylvain Choquet,
• Frederic Davi,
• Florence Nguyen-Khac,
• Wendy Cuccuini,
• Morgane Cheminant,
• Clotilde Bravetti,
• Gregory Lazarian,
• Sophie Kaltenbach,
• Olivier Hermine,
• Damien Roos-Weil,
• Marion Espéli,
• Karl Balabanian,
• Bertrand Arnulf

Affiliations

Pierre-Edouard Debureaux

INSERM U1160 EMiLy, Institut de Recherche Saint-Louis, Université Paris-Cité, Paris, France; Department of Immuno Hematology, Hospital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris

Nathalie Forgeard

Department of Immuno Hematology, Hospital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris, France; Sorbonne Université, Department of Hematology, Hospital Pitie-Salpetriere, Assistance Publique Hopitaux de Paris, Paris

Dikelele Elessa

Department of Immuno Hematology, Hospital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris

Stéphanie Harel

Department of Immuno Hematology, Hospital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris

Laurent Frenzel

Department of Hematology, Hospital Necker, Assistance Publique Hopitaux de Paris, Paris

Bruno Royer

Department of Immuno Hematology, Hospital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris

Alexis Talbot

Department of Immuno Hematology, Hospital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris

Sylvain Choquet

Sorbonne Université, Department of Hematology, Hospital Pitie-Salpetriere, Assistance Publique Hopitaux de Paris, Paris

Frederic Davi

Laboratory of Hematology, Hospital Pitie-Salpetriere, Assistance Publique Hopitaux de Paris, Paris

Florence Nguyen-Khac

Laboratory of Hematology, Hospital Pitie-Salpetriere, Assistance Publique Hopitaux de Paris, Paris, France; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, Inserm UMRS1138, Drug Resistance in Hematological Malignancies Team, Paris

Wendy Cuccuini

Laboratory of Cytogenetic, Hospital Saint Louis, Assistance Publique Hopitaux de Paris, Paris

Morgane Cheminant

Department of Hematology, Hospital Necker, Assistance Publique Hopitaux de Paris, Paris

Clotilde Bravetti

Laboratory of Hematology, Hospital Pitie-Salpetriere, Assistance Publique Hopitaux de Paris, Paris

Gregory Lazarian

Laboratory of Hematology, Hospital Avicenne, Assistance Publique Hopitaux de Paris, Paris

Sophie Kaltenbach

Laboratory of Hematology, Hospital Necker, Assistance Publique Hopitaux de Paris, Paris

Olivier Hermine

Department of Hematology, Hospital Necker, Assistance Publique Hopitaux de Paris, Paris

Damien Roos-Weil

Sorbonne Université, Department of Hematology, Hospital Pitie-Salpetriere, Assistance Publique Hopitaux de Paris, Paris

Marion Espéli

INSERM U1160 EMiLy, Institut de Recherche Saint-Louis, Université Paris-Cité, Paris

Karl Balabanian

INSERM U1160 EMiLy, Institut de Recherche Saint-Louis, Université Paris-Cité, Paris

Bertrand Arnulf

Department of Immuno Hematology, Hospital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris, France; University of Paris Cité, Paris